Principal Financial Group Inc. Has $38.26 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Principal Financial Group Inc. decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 6.7% in the fourth quarter, according to the company in its most recent ...
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven ...